{"id":"https://openalex.org/W3097618352","doi":"https://doi.org/10.1016/j.ymthe.2020.10.022","title":"Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies","display_name":"Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies","publication_year":2020,"publication_date":"2020-10-30","ids":{"openalex":"https://openalex.org/W3097618352","doi":"https://doi.org/10.1016/j.ymthe.2020.10.022","mag":"3097618352","pmid":"https://pubmed.ncbi.nlm.nih.gov/33130313","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7854294"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2020.10.022","doi":"https://doi.org/10.1016/j.ymthe.2020.10.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2020.10.022","pdf_url":"http://www.cell.com/article/S1525001620305931/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001620305931/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012987786","display_name":"Mark B. Leick","orcid":"https://orcid.org/0000-0003-3111-0221","observed_orcids":["https://orcid.org/0000-0003-3111-0221"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark B. Leick","raw_affiliation_strings":["Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA","Department of Medicine, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029763484","display_name":"Marcela Valderrama Maus","orcid":"https://orcid.org/0000-0002-7578-0393","observed_orcids":["https://orcid.org/0000-0002-7578-0393"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marcela V. Maus","raw_affiliation_strings":["Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mvmaus@mgh.harvard.edu","Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA","Department of Medicine, Harvard Medical School, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-7578-0393","affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mvmaus@mgh.harvard.edu","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064556004","display_name":"Matthew J. Frigault","orcid":"https://orcid.org/0000-0002-6774-5694","observed_orcids":["https://orcid.org/0000-0002-6774-5694"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Frigault","raw_affiliation_strings":["Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA","Department of Medicine, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029763484"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":0.6445,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.6185692,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"29","issue":"2","first_page":"433","last_page":"441"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/large-b-cell-lymphoma","display_name":"large B-cell lymphoma","score":0.9259999990463257},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8999999761581421},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8529999852180481},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.7979999780654907},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.8190000057220459},{"id":"https://openalex.org/keywords/bridging-therapy","display_name":"bridging therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/follow-up-care","display_name":"follow-up care","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.8233563899993896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6918811202049255},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.587199866771698},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5808432102203369},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.467671275138855},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46675539016723633},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45855090022087097},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4430948793888092},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42895135283470154},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.41826245188713074},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.41285955905914307},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3269961476325989},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.17268800735473633},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.15296465158462524},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12497463822364807},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10190638899803162},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ymthe.2020.10.022","doi":"https://doi.org/10.1016/j.ymthe.2020.10.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2020.10.022","pdf_url":"http://www.cell.com/article/S1525001620305931/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7854294","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7854294","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther","raw_type":"Text"},{"id":"pmid:33130313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33130313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2020.10.022","doi":"https://doi.org/10.1016/j.ymthe.2020.10.022","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2020.10.022","pdf_url":"http://www.cell.com/article/S1525001620305931/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W3097618352.pdf"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W1966738818","https://openalex.org/W1973444244","https://openalex.org/W2118796952","https://openalex.org/W2126772526","https://openalex.org/W2153520524","https://openalex.org/W2283468082","https://openalex.org/W2296829012","https://openalex.org/W2360020331","https://openalex.org/W2408097265","https://openalex.org/W2523343293","https://openalex.org/W2527524391","https://openalex.org/W2559431510","https://openalex.org/W2617968907","https://openalex.org/W2744261860","https://openalex.org/W2766745670","https://openalex.org/W2773804840","https://openalex.org/W2775369717","https://openalex.org/W2793826339","https://openalex.org/W2804159084","https://openalex.org/W2888063816","https://openalex.org/W2889582030","https://openalex.org/W2893691711","https://openalex.org/W2897148502","https://openalex.org/W2901133714","https://openalex.org/W2903062212","https://openalex.org/W2903225254","https://openalex.org/W2905654445","https://openalex.org/W2907015766","https://openalex.org/W2910778868","https://openalex.org/W2911431721","https://openalex.org/W2917676884","https://openalex.org/W2919051790","https://openalex.org/W2920899965","https://openalex.org/W2942621614","https://openalex.org/W2946307588","https://openalex.org/W2959588651","https://openalex.org/W2972701995","https://openalex.org/W2983410311","https://openalex.org/W2986264979","https://openalex.org/W2986836204","https://openalex.org/W2990046520","https://openalex.org/W2990485716","https://openalex.org/W2990627596","https://openalex.org/W2991246146","https://openalex.org/W2991612669","https://openalex.org/W2995487842","https://openalex.org/W2996162095","https://openalex.org/W3000719174","https://openalex.org/W3001823821","https://openalex.org/W3007925874","https://openalex.org/W3011327279","https://openalex.org/W3015500081","https://openalex.org/W3024978145","https://openalex.org/W3028800054","https://openalex.org/W3029839974","https://openalex.org/W3031492407","https://openalex.org/W3034030759","https://openalex.org/W3034162969","https://openalex.org/W3034763342","https://openalex.org/W3037322433","https://openalex.org/W3043369050","https://openalex.org/W4220921975","https://openalex.org/W6757068898"],"related_works":["https://openalex.org/W4399013664","https://openalex.org/W4206710025","https://openalex.org/W3017021401","https://openalex.org/W4214936979","https://openalex.org/W4214859401","https://openalex.org/W3038220775","https://openalex.org/W4389068171","https://openalex.org/W4400218628","https://openalex.org/W4412363554","https://openalex.org/W4200149492"],"abstract_inverted_index":{"Large":[0],"B":[1],"cell":[2,35],"lymphoma":[3],"(LBCL)":[4],"is":[5],"curable":[6],"with":[7,17],"standard":[8],"chemo-immunotherapy":[9],"in":[10],"the":[11,63,67],"majority":[12],"of":[13,69],"cases.":[14],"However,":[15],"patients":[16],"primary":[18],"refractory":[19],"or":[20],"relapsed":[21],"disease":[22],"have":[23,37],"historically":[24],"had":[25],"limited":[26],"treatment":[27],"options.":[28],"Two":[29],"gene-modified":[30,51],"chimeric":[31],"antigen":[32],"receptor":[33],"(CAR)-T":[34],"therapies":[36],"now":[38],"been":[39],"approved":[40],"for":[41],"these":[42,50,70],"indications.":[43],"The":[44],"clinical":[45,83],"decisions":[46],"and":[47,56,86],"management":[48],"surrounding":[49],"\"living":[52],"drugs\"":[53],"are":[54],"nuanced":[55],"complex.":[57],"In":[58],"this":[59],"article,":[60],"we":[61],"discuss":[62],"evolving":[64],"evidence":[65],"supporting":[66],"use":[68],"CAR-T":[71],"cells,":[72],"including":[73],"patient":[74],"selection,":[75],"screening":[76],"procedures,":[77],"special":[78],"populations,":[79],"bridging":[80],"therapy,":[81],"lymphodepletion,":[82],"management,":[84],"relapse,":[85],"follow":[87],"up.":[88]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-11-09T00:00:00"}